Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan CEO grilled by Congress over EpiPen price hikes

Mylan CEO Heather Bresch testified in front of the U.S. House Committee on Oversight and Government Reform about the price hike of EpiPens.